These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 37788924)
1. Correlation of drug exposure and bacterial susceptibility with treatment response for Zheng X; Wang L; Davies Forsman L; Zhang Y; Chen Y; Luo X; Liu Y; Bruchfeld J; Hu Y; Alffenaar JC; Sha W; Xu B BMJ Open; 2023 Oct; 13(10):e075383. PubMed ID: 37788924 [TBL] [Abstract][Full Text] [Related]
2. Difference in drug susceptibility distribution and clinical characteristics between Wang W; Yang J; Wu X; Wan B; Wang H; Yu F; Guo Y J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797 [No Abstract] [Full Text] [Related]
3. Relationship between Resistance to Ethambutol and Rifampin and Clinical Outcomes in Mycobacterium avium Complex Pulmonary Disease. Moon SM; Kim SY; Kim DH; Huh HJ; Lee NY; Jhun BW Antimicrob Agents Chemother; 2022 Apr; 66(4):e0202721. PubMed ID: 35266825 [TBL] [Abstract][Full Text] [Related]
4. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease. Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764 [TBL] [Abstract][Full Text] [Related]
5. Comparing the Genotype and Drug Susceptibilities between Mycobacterium avium and Mycobacterium intracellulare in China. Zheng HW; Pang Y; He GX; Song YY; Zhao YL Biomed Environ Sci; 2017 Jul; 30(7):517-525. PubMed ID: 28756811 [TBL] [Abstract][Full Text] [Related]
6. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?]. Ogawa K; Sano C Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176 [TBL] [Abstract][Full Text] [Related]
7. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients. Ramirez J; Mason C; Ali J; Lopez FA J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand. Sirichoat A; Kaewprasert O; Hinwan Y; Faksri K PLoS One; 2023; 18(11):e0294677. PubMed ID: 37992075 [TBL] [Abstract][Full Text] [Related]
9. [Clinical study on development of nontuberculous mycobacterial lung disease]. Kurashima A Kekkaku; 2004 Dec; 79(12):737-41. PubMed ID: 15782619 [TBL] [Abstract][Full Text] [Related]
10. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates. Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258 [TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease. Moon SM; Park HY; Kim SY; Jhun BW; Lee H; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Koh WJ Antimicrob Agents Chemother; 2016 Nov; 60(11):6758-6765. PubMed ID: 27572413 [TBL] [Abstract][Full Text] [Related]
12. [Non-tuberculous mycobacteriosis. What has been coming out]. Kajiki A Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655 [TBL] [Abstract][Full Text] [Related]
13. Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan. Yamaba Y; Ito Y; Suzuki K; Kikuchi T; Ogawa K; Fujiuchi S; Hasegawa N; Kurashima A; Higuchi T; Uchiya KI; Watanabe A; Niimi A J Infect Chemother; 2019 Dec; 25(12):995-1000. PubMed ID: 31239192 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines. Ku JH; Henkle E; Carlson KF; Marino M; Brode SK; Marras TK; Winthrop KL Clin Infect Dis; 2023 Feb; 76(3):e1408-e1415. PubMed ID: 35607719 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates. Brown-Elliott BA; Iakhiaeva E; Griffith DE; Woods GL; Stout JE; Wolfe CR; Turenne CY; Wallace RJ J Clin Microbiol; 2013 Oct; 51(10):3389-94. PubMed ID: 23946523 [TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014 [TBL] [Abstract][Full Text] [Related]
17. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. Fröberg G; Maurer FP; Chryssanthou E; Fernström L; Benmansour H; Boarbi S; Mengshoel AT; Keller PM; Viveiros M; Machado D; Fitzgibbon MM; Mok S; Werngren J; Cirillo DM; Alcaide F; Hyyryläinen HL; Aubry A; Andres S; Nadarajan D; Svensson E; Turnidge J; Giske CG; Kahlmeter G; Cambau E; van Ingen J; Schön T; Clin Microbiol Infect; 2023 Jun; 29(6):758-764. PubMed ID: 36813087 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease. Maekura R; Miki K; Tateishi Y; Matsumoto S; Kitada S; Miki M; Kida H Microbiol Spectr; 2022 Jun; 10(3):e0053022. PubMed ID: 35467367 [TBL] [Abstract][Full Text] [Related]
19. Bigger problems from smaller colonies: emergence of antibiotic-tolerant small colony variants of Mycobacterium avium complex in MAC-pulmonary disease patients. Park HE; Kim KM; Trinh MP; Yoo JW; Shin SJ; Shin MK Ann Clin Microbiol Antimicrob; 2024 Mar; 23(1):25. PubMed ID: 38500139 [TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study. Davies Forsman L; Niward K; Hu Y; Zheng R; Zheng X; Ke R; Cai W; Hong C; Li Y; Gao Y; Werngren J; Paues J; Kuhlin J; Simonsson USH; Eliasson E; Alffenaar JW; Mansjö M; Hoffner S; Xu B; Schön T; Bruchfeld J BMJ Open; 2018 Oct; 8(9):e023899. PubMed ID: 30287613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]